Finerenone cardiovascular and kidney outcomes by age and sex: FIDELITY post hoc analysis of two phase 3, multicentre, double-blind trials - Bansal, Shweta; Canziani, Maria E F; Birne, Rita; Anker, Stefan D; Bakris, George L; Filippatos, Gerasimos; Rossing, Peter; Ruilope, Luis M; Farjat, Alfredo E; Kolkhof, Peter; Lage, Andrea; Brinker, Meike; et al. (BMJ open, 2024)
Keywords: Adult; Age; Blood pressure; cardiovascular disease; Clinical outcomes; Clinical trials; Diabetes; diabetes & endocrinology; Diabetes and Endocrinology; Diabetes Mellitus, Type 2 - complications; diabetic nephropathy & vascular disease; Double-Blind Method; Female; Females; Heart Failure - complications; Hormones; Humans; Kidney; Kidney diseases; Male; Males; Middle Aged; Naphthyridines - therapeutic use; Patients; Potassium; Renal Insufficiency, Chronic - complications; Renal Insufficiency, Chronic - drug therapy; risk factors; cardiovascular disease; risk factors; diabetic nephropathy & vascular disease; diabetes & endocrinology